申请人:Schering Aktiengesellschaft
公开号:US05440044A1
公开(公告)日:1995-08-08
The present invention relates to a leukotriene-B.sub.4 analog according to formula I ##STR1## in which R.sup.1 is a COOR.sup.2 group, wherein R.sup.2 is a C.sub.2-4 -alkyl group; B is a C.sub.1-3 -alkylene group, a radical ##STR2## wherein R.sup.3 is a hydrogen atom or a carboxy or methoxycarbonyl group; ##STR3## . . . is a single or double bond; or optionally, their salts with physiologically compatible bases. The present invention also relates to the production of the latter leukotriene-B.sub.4 analogs and their use as pharmacological agents.
本发明涉及一种类似白三烯-B.sub.4的化合物,其化学式为I,其中R.sup.1是COOR.sup.2基团,其中R.sup.2是C.sub.2-4-烷基基团;B是C.sub.1-3-烷基基团,一个基团##STR2##其中R.sup.3是氢原子或羧基或甲氧羰基基团;##STR3## 是单键或双键;或者它们与生理兼容碱的盐。本发明还涉及制备这些白三烯-B.sub.4类似物以及它们作为药理学药剂的用途。